Ironwood Pharmaceuticals IRWD Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $215.46M+143% | $88.56M-3.9% | $92.15M-86.0% | $656.2M+5.8% | ||
| $46.75M-42.9% | $81.89M-36.6% | $129.12M+11.8% | $115.46M+1.2% | ||
| $274.18M+50.3% | $182.37M-21.8% | $233.29M-70.1% | $780.63M+4.8% | ||
| $3.41M-24.2% | $4.5M-19.5% | $5.59M-11.2% | $6.29M-17.0% | ||
| $2.04M-28.7% | $2.86M-22.3% | $3.68M— | —— | ||
| $396.9M+13.1% | $350.91M-25.5% | $471.07M-57.2% | $1.1B-2.3% | ||
| $2.9M+36.2% | $2.13M-72.8% | $7.83M+1,521% | $483K-48.3% | ||
| $199.68M— | —— | $199.56M— | —— | ||
| $242.22M+524% | $38.85M-85.9% | $276.1M+982% | $25.53M-84.2% | ||
| $163K+1.9% | $160K+2.6% | $156K+1.3% | $154K-4.9% | ||
| -$1.67B+1.4% | -$1.7B+0.1% | -$1.7B-144% | -$696.38M+25.7% | ||
| -$261.84M+13.1% | -$301.34M+13.0% | -$346.3M-153% | $652.38M+7.7% | ||
| $396.9M+13.1% | $350.91M-25.5% | $471.07M-57.2% | $1.1B-2.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ironwood Pharmaceuticals's total assets?
- Ironwood Pharmaceuticals (IRWD) holds $434.6M in total assets, up 32.8% year over year.
- How much debt does Ironwood Pharmaceuticals have?
- Ironwood Pharmaceuticals carries $212.4M in total debt against -$217.1M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Ironwood Pharmaceuticals have?
- Ironwood Pharmaceuticals holds $220.5M in cash and equivalents.
- Can Ironwood Pharmaceuticals cover its short-term obligations?
- Its current ratio is 1.41 — current assets exceed current liabilities.
- Where does Ironwood Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
